Efficacy of serotherapy in scorpion sting: A matched-pair study

Journal of Toxicology - Clinical Toxicology

Volumn 37, Issue 1, 1999, Pages 51-57

  Belghith, Makhlouf ^a   Boussarsar, Mohamed ^b   Haguiga, Habib ^c   Besbes, Lamia ^b   Elatrous, Souheil ^b   Touzi, Naceur ^c   Boujdaria, Rafik ^b   Bchir, Afef ^a   Nouira, Semir ^b   Bouchoucha, Slah ^a   Abroug, Fekri ^b  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^c Hopital Regional   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; SCORPION VENOM; VENOM ANTISERUM;

ADJUVANT THERAPY; ADULT; AGED; ANAPHYLACTIC SHOCK; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; EMERGENCY TREATMENT; ENVENOMATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; SCORPION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIVENINS; ARACHNIDISM; CHILD; FEMALE; HUMANS; HYDROCORTISONE; IMMUNIZATION, PASSIVE; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDIES; SCORPION VENOMS; SCORPIONS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC;

SCORPIONES;

EID: 0032977527     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100102408     Document Type: Article

References (25)

1. Gueron M, Ilia R, Sofer S. The cardiovascular system after scorpion envenomation. A review. J Toxicol Clin Toxicol 1992;30:245-258.
2. Abroug F, Nouira S, Haguiga H, et al. A randomised clinical trial of high-dose hydrocortisone hemisuccinate in scorpion envenomation. Ann Emerg Med 1997;30:245-258.
3. Ismail M. The scorpion envenoming syndrome. Toxicon 1995;33:825-858.
4. Ismail M, Fatani AJ, Dabees TT. Experimental treatment protocols for scorpion envenomation: A review of common therapies and an effect of kallikrein-kinin inhibitors. Toxicon 1992;30:1257-1279.
5. Bond GR. Antivenin administration for centruroïdes scorpion sting: Risks and benefits. Ann Emerg Med 1992;21:788-791.
6. Muller GJ. Scorpionism in South Africa. A report of 42 serious scorpion envenomations. S Afr Med J 1993;83:405-411.
7. el-Amin EO, Sultan OM, al-Magamci AI, Elidrissy A. Serotherapy in the management of scorpion sting in children in Saudi Arabia. Ann Trop Paediatr 1994;14:21-24.
8. Gateau T, Bloom M, Clark R. Response to specific Centruroïdes sculpturatus antivenom in 151 cases of scorpion stings. J Toxicol Clin Toxicol 1994;32:165-171.
9. Dehesa-Davila M, Possani LD. Scorpionism and serotherapy in Mexico. Toxicon 1994;32:1015-1018.
10. Freire-Maia L, Campos JA, Amaral CF. Approaches to the treatment of scorpion envenoming. Toxicon 1994;32:1009-1014.
11. Ismail M. The treatment of the scorpion envenoming syndrome: The Saudi experience with serotherapy. Toxicon 1994-32:1019-1026.
12. Sofer S, Shahak E, Gueron M. Scorpion envenomation and antivenom therapy. J Pediatr 1994;124: 973-978.
13. Bawaskar HS, Bawaskar PH. Treatment of cardiovascular manifestations of human scorpion envenoming: Is serotherapy essential? J Trop Med Hyg 1991;94: 156-158.
14. Gueron M, Margulis G, Ilia R, Sofer S. The management of scorpion envenomation 1993. Toxicon 1993; 31:1071-1083.
15. Ismail M. Serotherapy of the scorpion envenoming syndrome is irrationally convicted without trial. Toxicon 1993;31:1077-1083.
16. De Rezende NA, Dias MB, Campolina D, Chavez-Olortegui C, Diniz CR, Amaral CF. Efficacy of antivenom therapy for neutralizing circulating venom antigens in patients stung by Tityus serrulatus scorpions. Am J Trop Med Hyg 1995;52:277-280.
17. Goyffon M, Vachon M, Broglio N. Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon 1982;20:337-344.
18. Ismail M, Abdullah ME, Morad AM, Ageel AM. Pharmacokinetics of 1251-labelled venom from the scorpion Androctonus amoreuxi (Aud. and Sav.) Toxicon 1980;18:301-308.
19. Ismail M, Shibl AM, Morad AM, Abdullah ME. Pharmacokinetics of 1251-labelled antivenom to the venom from the scorpion Androctonus amoreuxi. Toxicon 1983;21:47-56.
20. Tarasiuk A, Khvatskin S, Sofer S. Effects of antivenom serotherapy on hemodynamic pathophysiology in dogs injected with L. quinquestriatus scorpion venom. Toxicon 1998;36:963-971.
21. Amitai Y, Mines Y, Aker M, Goitein K. Scorpion sting in children. A review of 51 cases. Child Pediatr (Phila) 1985:24:136-140.
22. Hershkovich Y, Elitsnr Y, Margolis C. Criteria map of scorpion envenomation in the Neguev. Toxicon 1985;45:979-986.
23. Gwee MC, Cheah LS, Gopalakrishnakone P. Involvement of the L-arginine-nitric oxide synthase pathway in the relaxant responses of the rat isolated anococcygenus muscle to a scorpion (Leiurus quinquestriatus quinquestriatus) venom. Toxicon 1995;33:1141-1150.
24. Freire-Maia L, Dematos IM. Heparin or a PAF antagonist (Bon-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. Toxicon 1993;31:1207-1210.
25. Sofer S, Gueron M, White RM, Lifshitz M, Apte RN. Interleukin-6 release following scorpion sting in children. Toxicon 1996;34:389-392.